Current Ratio of Regen BioPharma Inc from 31 Dec 2014 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Regen BioPharma Inc quarterly Current Ratio in x history and change rate from 31 Dec 2014 to 31 Dec 2025.
- Regen BioPharma Inc Current Ratio for the quarter ending 31 Dec 2025 was 0.03x, a 23% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Regen BioPharma Inc Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 0.03x | +0.01x | +23% | 31 Dec 2025 |
| Q3 2025 | 0.03x | +0.01x | +21% | 30 Sep 2025 |
| Q2 2025 | 0.03x | +0x | +7.6% | 30 Jun 2025 |
| Q1 2025 | 0.03x | +0.01x | +27% | 31 Mar 2025 |
| Q4 2024 | 0.03x | +0x | +11% | 31 Dec 2024 |
| Q3 2024 | 0.03x | -0x | -0.91% | 30 Sep 2024 |
| Q2 2024 | 0.03x | -0.01x | -17% | 30 Jun 2024 |
| Q1 2024 | 0.02x | -0.02x | -47% | 31 Mar 2024 |
| Q4 2023 | 0.02x | +0.01x | +63% | 31 Dec 2023 |
| Q3 2023 | 0.03x | +0.01x | +44% | 30 Sep 2023 |
| Q2 2023 | 0.03x | +0.01x | +35% | 30 Jun 2023 |
| Q1 2023 | 0.04x | +0.02x | +86% | 31 Mar 2023 |
| Q4 2022 | 0.02x | -0.03x | -69% | 31 Dec 2022 |
| Q3 2022 | 0.02x | -0.02x | -56% | 30 Sep 2022 |
| Q2 2022 | 0.02x | -0x | -1.8% | 30 Jun 2022 |
| Q1 2022 | 0.02x | +0x | +27% | 31 Mar 2022 |
| Q4 2021 | 0.05x | +0.04x | +289% | 31 Dec 2021 |
| Q3 2021 | 0.04x | +0.03x | +397% | 30 Sep 2021 |
| Q2 2021 | 0.02x | +0.02x | +243% | 30 Jun 2021 |
| Q1 2021 | 0.02x | +0.01x | +210% | 31 Mar 2021 |
| Q4 2020 | 0.01x | +0.01x | +179% | 31 Dec 2020 |
| Q3 2020 | 0.01x | +0x | +27% | 30 Sep 2020 |
| Q2 2020 | 0.01x | +0x | +14% | 30 Jun 2020 |
| Q1 2020 | 0.01x | -0x | -32% | 31 Mar 2020 |
| Q4 2019 | 0x | -0.01x | -69% | 31 Dec 2019 |
| Q3 2019 | 0.01x | -0.02x | -78% | 30 Sep 2019 |
| Q2 2019 | 0.01x | -0.04x | -87% | 30 Jun 2019 |
| Q1 2019 | 0.01x | -0.06x | -88% | 31 Mar 2019 |
| Q4 2018 | 0.01x | -0.08x | -84% | 31 Dec 2018 |
| Q3 2018 | 0.03x | -0.1x | -77% | 30 Sep 2018 |
| Q2 2018 | 0.05x | -0.13x | -74% | 30 Jun 2018 |
| Q1 2018 | 0.07x | -0.19x | -73% | 31 Mar 2018 |
| Q4 2017 | 0.09x | -0.26x | -73% | 31 Dec 2017 |
| Q3 2017 | 0.13x | -0.2x | -60% | 30 Sep 2017 |
| Q2 2017 | 0.18x | -0.16x | -47% | 30 Jun 2017 |
| Q1 2017 | 0.26x | -0.27x | -51% | 31 Mar 2017 |
| Q4 2016 | 0.35x | -0.69x | -66% | 31 Dec 2016 |
| Q3 2016 | 0.33x | -0.59x | -64% | 30 Sep 2016 |
| Q2 2016 | 0.33x | -0.72x | -68% | 30 Jun 2016 |
| Q1 2016 | 0.52x | -0.42x | -44% | 31 Mar 2016 |
| Q4 2015 | 1.04x | +0.57x | +121% | 31 Dec 2015 |
| Q3 2015 | 0.92x | 30 Sep 2015 | ||
| Q2 2015 | 1.06x | 30 Jun 2015 | ||
| Q1 2015 | 0.94x | 31 Mar 2015 | ||
| Q4 2014 | 0.47x | 31 Dec 2014 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.